Skip to main content
. 2022 Dec 23;13(1):48. doi: 10.3390/diagnostics13010048

Table 3.

Increased Nuchal Translucency and Prenatal/Postnatal Outcome-systematic review.

Nuchal Translucency
Reference Dimension
(mm)
Association Miscarriages Intrauterine Deaths Live Births Perinatal Death Intellectual Disability Major Childhood
Morbidity
[52] ≥3.5 apparently isolated-euploid 0/20
(0.00%)
1/20
(5.00%)
19/20
(95.00%)
1/19
(5.26%)
3/19
(15.79%)
3/19
(15.79%)
[63] ≥3.5 unspecified-euploid . 5/33
(15.15%)
28/33
(84.85%)
. . .
[64] ≥3.5 unspecified-euploid 4/420
(0.95%)
. . . 10/270
(3.70%)
10/370
(2.70%)
[65] ≥3.5 unspecified-euploid 6/52
(11.54%)
. 46/52
(88.46%)
. . 6/46
(13.04%)
[66] ≤3.0 unspecified 45/1395
(3.23%)
19/1395
(1.36%)
1305/1395
(93.55%)
. . .
≥3.0 unspecified 22/105
(20.95%)
15/105
(14.29%)
33/105
(31.43%)
. . .
3.0–4.0 unspecified 10/52
(19.23%)
5/52
(9.62%)
28/52
(53.85%)
. . .
4.0–5.0 unspecified 10/33
(30.30%)
7/33
(21.21%)
5/33
(15.15%)
. . .
5.0–6.0 unspecified 2/15
(13.33%)
3/15
(20.00%)
0/15
(0.00%)
. . .
≥6.0 unspecified 0/5
(0.00%)
0/5
(0.00%)
0/5
(0.00%)
. . .
[68] ≥3.0 associated-euploid . . 741/834
(88.85%)
. . 43/741
(5.80%)
3–3.4 associated-euploid . . 562/611
(91.98%)
. . 28/562
(4.98%)
3.5–4.4 associated-euploid . . 141/157
(89.81%)
. . 7/141
(4.96%)
4.5–5.4 associated-euploid . . 30/38
(78.95%)
. . 2/30
(6.67%)
5.5–6.4 associated-euploid . . 5/11
(45.45%)
. . 4/5
(80.00%)
≥6.5 associated-euploid . . 3/17
(17.65%)
. . 2/3
(66.76%)
[102] ≥3.0 unspecified . 0/46
(0.00%)
31/46
(67.39%)
3/31
(9.68%)
. 3/31
(9.68%)
[73] ≥99ct associated-euploid . 4/36
(11.11%)
13/36
(36.11%)
1/6
(16.67%)
. 6/13
(46.15%)
≥99ct apparently isolated-euploid 2/70
(2.86%)
1/70
(1.73%)
63/70
(90.00%)
. . 3/63
(4.76%)
[103] ≥95ct unspecified-euploid 23/625
(3.68%)
. . . . .
[80] ≥3.5 unspecified-euploid 5/139
(3.60%)
1/139
(0.72%)
110/139
(79.14%)
. . 7/110
(6.36%)
3.5–4.4 unspecified-euploid 2/86
(2.33%)
1/86
(1.16%)
77/86
(89.53%)
. . 3/77
(3.90%)
4.5–5.4 unspecified-euploid 0/28
(0.00%)
0/28
(0.00%)
20/28
(71.43%)
. . 2/20
(10.00%)
5.5–6.4 unspecified-euploid 1/12
(8.33%)
0/12
(0.00%)
7/12
(58.33%)
. . 1/7
(14.29%)
≥6.5 unspecified-euploid 2/13
(15.38%)
0/13
(0.00%)
6/13
(46.15%)
. . 1/6
(16.67%)
[82] ≥95ct unspecified . 9/239
(3.77%)
210/239
(87.87%)
. . 10/210
(4.76%)
95ct–3.4 unspecified . 2/139
(1.44%)
135/139
(97.12%)
. . 2/135
(1.48%)
3.5–4.4 unspecified . 2/52
(3.85%)
46/52
(88.46%)
. . 2/46
(4.35%)
4.5–5.4 unspecified . 2/19
(10.53%)
16/19
(84.21%)
. . 1/16
(6.25%)
5.5–6.4 unspecified . 0/8
(0.00%)
4/8
(50.00%)
. . 0/4
(0.00%)
≥6.5 unspecified . 3/21
(14.29%)
9/21
(42.86%)
. . 5/9
(55.56%)
[83] ≥95ct unspecified 7/149
(4.70%)
. 110/149
(73.83%)
. . .
95ct–3.4 unspecified 1/82
(1.22%)
. 71/82
(86.59%)
. . .
3.5–4.4 unspecified 2/43
(4.65%)
. 35/43
(81.40%)
. . .
4.5–5.4 unspecified 0/7
(0.00%)
. 2/7
(28.57%)
. . .
5.5–6.4 unspecified 3/8
(37.50%)
. 1/8
(12.50%)
. . .
≥6.5 unspecified 1/19
(5.26%)
. 1/19
(5.26%)
. . .
[84] 2.5–4.4 unspecified 4/33
(12.12%)
0/33
(0.00%)
20/33
(60.61%)
. . .
4.5–6.4 unspecified 1/8
(12.5%)
0/8
(0.00%)
1/8
(12.50%)
. . .
≥6.5 unspecified 2/13
(15.38%)
4/13
(30.77%)
1/13
(7.69%)
. . .
[85] ≥99ct unspecified-euploid 1/179
(0.56%)
5/179
(2.79%)
162/179
(90.50%)
. . 18/162
(11.11%)
[86] ≥4.0 unspecified . 2/89
(2.25%)
68/89
(76.40%)
. 4/64
(6.25%)
4/68
(5.88%)
[87] ≥6.5 unspecified-euploid 6/27
(22.22%)
. 8/27
(29.63%)
. . .
[88] ≥95ct unspecified-euploid . 10/103
(9.71%)
87/103
(84.47%)
. . 10/87
(11.49%)